By definition, precision medicine, which is often also referred to as personalized medicine, is the medical approach to understanding how an individual’s genetics, environment, and lifestyle can be used to determine the best method of disease treatment or prevention.

Precision medicine differs greatly from the traditional approach to disease treatment, which instead utilizes a “one-size-fits-all” approach that is limited in its ability to consider the unique differences that exist between each patient.

Today, there are numerous clinical applications of precision medicine that are expected to continue to shape how medicine and research are conducted for years to come. Precision medicine has been particularly successful in targeting various aspects of DNA in the treatment of various diseases, particularly cancer.[1]

Figure 1. The Future of Precision Medicine Symposium 2021

Figure 1 shows This two-day symposium on the future of precision medicine will feature lectures and panel discussions on precision diagnostics, precision prevention, pediatric precision medicine, clinical implementation, health disparities, the power of big data, patient perspectives, and policy and implementation, with a focus on the opportunities and barriers for the implementation of precision medicine in research and practice.

The symposium will also celebrate the winner of the EFSD and Novo Nordisk Foundation Precision Diabetes Medicine Award. The award honours innovative research in both clinical and basic science that are likely to minimise the future burden of diabetes and other chronic disease. [2]

Precision Medicine

The falling costs of gene editing and gene sequencing make them more routinely applied in clinical practice. It enables precision medicine, an approach that allows physicians to determine which treatment and prevention strategies will work for a particular group. Moreover, it enables personalized treatment for the treatment of several diseases, including cancers. Biotech startups are leveraging precision medicine to identify new drug targets, discover novel drugs, offer gene therapies, and develop new drug delivery technologies.

iLoF offers Personalized Therapies

British startup iLoF offers a precise, patient-centric drug development platform. The blood-based platform finds biological nanostructures in liquid dispersions such as plasma. The platform is rapid and non-invasive and facilitates the development of precise and personalized therapies. The startup’s screening test classifies patients for clinical trials.

Dyno Therapeutics develops Gene Therapy

Dyno Therapeutics is a US-based startup developing AI-powered gene therapies. The startup’s CapsidMap platform optimizes adeno-associated viral (AAV) vectors to improve targeting ability. The solution maps the synthetic AAV capsid sequence space to develop better gene therapy vectors.[3]

References:

1. https://www.news-medical.net/life-sciences/The-Future-of-Precision-Medicine.aspx
2. https://novonordiskfonden.dk/en/events/future-of-precision-medicine-symposium-2021/
3. https://www.startus-insights.com/innovators-guide/top-10-biotech-industry-trends-innovations-in-2021/

Cite this article:

Thanusri swetha J (2021), Future of Precision Medicine Symposium 2021, AnaTechmaz, pp. 11